BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Biomedical Mathematics Group - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.ibs.re.kr/bimag
X-WR-CALDESC:Events for Biomedical Mathematics Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Seoul
BEGIN:STANDARD
TZOFFSETFROM:+0900
TZOFFSETTO:+0900
TZNAME:KST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Seoul:20260227T100000
DTEND;TZID=Asia/Seoul:20260227T113000
DTSTAMP:20260404T055454
CREATED:20260219T012250Z
LAST-MODIFIED:20260219T012250Z
UID:12219-1772186400-1772191800@www.ibs.re.kr
SUMMARY:TwinCell: Large Causal Cell Model for Reliable and Interpretable Therapeutic Target Prioritisation - Yun Min Song
DESCRIPTION:In this talk\, we discuss the paper “TwinCell: Large Causal Cell Model for Reliable and Interpretable Therapeutic Target Prioritisation” by J.-B. Morlot et al.\, bioarxiv\, 2026. \nAbstract \nDrug discovery is impeded by the difficulty of translating targets from preclinical models to patients. Here\, we present TwinCell\, a Large Causal Cell Model (LCCM) capable of generalising from in vitro cell lines to patient-derived cell types while providing biologically meaningful interpretations of its predictions. Rather than predicting perturbation outcomes\, TwinCell focuses on identifying the upstream regulators driving the transition between diseased and healthy states. By integrating single-cell foundation model embeddings with a multiomics interactome\, TwinCell constrains predictions to mechanistically plausible signalling routes. To validate this approach\, we introduce TwinBench\, a novel benchmarking framework to assess virtual cell models generalisation capability while correcting for popularity bias and mode collapse through empirical p-value estimation. When applied to in clinico data\, TwinCell recovers known drug targets aligned with the biology of the disease and demonstrates generalisation performance on targets unseen during training. This highlights the model’s ability to learn mechanistic principles in a biological context. TwinCell represents a significant step toward building reliable and interpretable virtual cells for target identification bridging the gap between high-throughput in vitro experiments and clinical insights.
URL:https://www.ibs.re.kr/bimag/event/twincell-large-causal-cell-model-for-reliable-and-interpretable-therapeutic-target-prioritisation-yun-min-song/
LOCATION:B232 Seminar Room\, IBS\, 55 Expo-ro Yuseong-gu\, Daejeon\, Daejeon\, 34126\, Korea\, Republic of
CATEGORIES:Journal Club
ORGANIZER;CN="Jae Kyoung Kim":MAILTO:jaekkim@kaist.ac.kr
END:VEVENT
END:VCALENDAR